Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Asmaa M. Zahran MD, PhD"'
Autor:
Omnia El-Badawy MD, PhD, Nahla M. Elsherbiny MD, PhD, Doaa Abdeltawab MD, PhD, Doaa M. Magdy MD, PhD, Lamees M. Bakkar MD, PhD, Shimaa A. Hassan MD, PhD, Elham A. Hassan MD, PhD, Ahmed M. Thabet MD, PhD, Ahmed M. Ashmawy MD, PhD, Ehab F. Moustafa MD, PhD, Wael A. Abbas MD, PhD, Ahmad Bahieldeen Ahmad MD, PhD, Amal Rayan MD, PhD, Khaled Saad MD, PhD, Amira Elhoufey PhD, Hosni A. M. Hussein PhD, Ali A. Thabet PhD, Asmaa M. Zahran MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Aim Our study's objectives were to study the clinical and laboratory characteristics that may serve as biomarkers for predicting disease severity, IL-10 levels, and frequencies of different T cell subsets in comorbid COVID-19 patients. Methods Sixty-
Externí odkaz:
https://doaj.org/article/daa7564817004c06adb966d770e053c4